Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase EARLY_PHASE1 2Phase 4 2Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 1Leukemia 1Bone Marrow Failure Disorders 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER × posaconazole × Clear all
NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Children's Mercy Hospital Kansas City

Phase 1 Completed
31 enrolled
Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡